Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
Front Endocrinol (Lausanne)
; 13: 899616, 2022.
Article
en En
| MEDLINE
| ID: mdl-35574017
[This corrects the article DOI: 10.3389/fendo.2021.662865.].
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
Front Endocrinol (Lausanne)
Año:
2022
Tipo del documento:
Article
País de afiliación:
Italia